Matinas BioPharma Holdings, Inc. MTNB
AMEX · United States · Health Technology
$2.42-0.13 (-5.10%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise |
|---|---|---|---|---|
| Q4 2024 | 2025-04-15 | -12.08 | -11.70 | -3.2% |
| Q3 2024 | 2024-11-13 | -12.75 | -15.82 | +19.4% |
| Q2 2024 | 2024-08-14 | -15.00 | -15.00 | 0.0% |
| Q4 2023 | 2024-03-27 | -22.50 | -22.50 | 0.0% |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.